Summit Creek Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Omnicell
OMCL
|
+$6.02M |
| 2 |
LOGM
LogMein, Inc.
LOGM
|
+$5.36M |
| 3 |
LeMaitre Vascular
LMAT
|
+$5.06M |
| 4 |
RP
RealPage, Inc.
RP
|
+$4.76M |
| 5 |
Grand Canyon Education
LOPE
|
+$4.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$13.1M |
| 2 |
Maximus
MMS
|
+$7.97M |
| 3 |
Synaptics
SYNA
|
+$7.94M |
| 4 |
SPS Commerce
SPSC
|
+$7.23M |
| 5 |
CAVM
Cavium, Inc.
CAVM
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.52% |
| 2 | Healthcare | 25.02% |
| 3 | Consumer Discretionary | 17.51% |
| 4 | Industrials | 13.89% |
| 5 | Financials | 4.61% |
Similar funds
Summit Creek Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Summit Creek Advisors held 56 positions worth $476M, down 18% from $585M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Summit Creek Advisors withdrew a net $148M in Q1 2017, closing 5 positions and reducing 42 holdings. Its most notable exit was Cynosure, Inc. Class A, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Summit Creek Advisors opened a new position in LeMaitre Vascular worth $5.31M.
- Summit Creek Advisors's largest Q1 2017 buy was LeMaitre Vascular: 215,616 shares worth $5.31M.
- Summit Creek Advisors added most to Omnicell in Q1 2017, an estimated $6.02M increase.
- Summit Creek Advisors's biggest Q1 2017 reduction was Maximus, cutting an estimated $7.97M.
- Summit Creek Advisors fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $13.1M.
- Summit Creek Advisors's ten largest holdings make up 30% of its $476M portfolio in Q1 2017.
- Summit Creek Advisors opened 4 new positions and closed 5 in Q1 2017.
- Summit Creek Advisors's portfolio value fell 18% quarter-over-quarter to $476M.
Based on Summit Creek Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.